The current state of randomized clinical trial evidence for prostate brachytherapy

被引：9

作者：

Dess, Robert T. ^{[1
]}

Soni, Payal D. ^{[2
]}

Jackson, William C. ^{[1
]}

Berlin, Alejandro ^{[3
]}

Cox, Brett W. ^{[4
]}

Jolly, Shruti ^{[1
]}

Efstathiou, Jason A. ^{[5
]}

Feng, Felix Y. ^{[6
,7
,8
]}

Kishan, Amar U. ^{[9
]}

Stish, Bradley J. ^{[10
]}

Pisansky, Thomas M. ^{[10
]}

Spratt, Daniel E. ^{[1
]}

机构：

[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA

[2] Hunter Holmes McGuire VA Med Ctr, Dept Radiat Oncol, Richmond, VA USA

[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada

[4] Northwell Hlth, Hofstra Northwell Sch Med, Dept Radiat Med, Hempstead, NY USA

[5] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA

[6] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA

[7] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA

[8] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[9] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA

[10] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2019年 / 37卷 / 09期

关键词：

Prostate cancer; Brachytherapy; LDR; HDR; Combination therapy; HIGH-DOSE-RATE; EXTERNAL-BEAM RADIATION; TERM ANDROGEN DEPRIVATION; SOCIETY CONSENSUS GUIDELINES; LOCALLY ADVANCED CANCER; CELL LUNG-CANCER; TROG; 03.04; RADAR; QUALITY-OF-LIFE; PHASE-II; AMERICAN BRACHYTHERAPY;

D O I：

10.1016/j.urolonc.2019.04.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Interstitial brachytherapy is one of several curative therapeutic options for the treatment of localized prostate cancer. In this review, we summarize all available randomized data to support the optimal use of prostate brachytherapy. Evidence from completed randomized controlled trials is the focus of this review with a presentation also of important ongoing trials. Gaps in knowledge are identified where future investigation may be fruitful with intent to inspire well-designed prospective studies with standardized treatment that focuses on improving oncological outcomes, reducing morbidity, or maintaining quality of life. (C) 2019 Elsevier Inc. All rights reserved.

引用

页码：599 / 610

页数：12

共 76 条

[1] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805 [J].

ALBAIN, KS ;

RUSCH, VW ;

CROWLEY, JJ ;

RICE, TW ;

TURRISI, AT ;

WEICK, JK ;

LONCHYNA, VA ;

PRESANT, CA ;

MCKENNA, RJ ;

GANDARA, DR ;

FOSMIRE, H ;

TAYLOR, SA ;

STELZER, KJ ;

BEASLEY, KR ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1880-1892

[2]

[Anonymous], J CLIN ONCOL

[3] Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? [J].

Arcangeli, Stefano ;

Greco, Carlo .

NATURE REVIEWS UROLOGY, 2016, 13 (07) :400-408

[4]

Barringer BS, 1917, J AMER MED ASSOC, V68, P1227

[5] External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study [J].

Bolla, Michel ;

Van Tienhoven, Geertjan ;

Warde, Padraig ;

Dubois, Jean Bernard ;

Mirimanoff, Rene-Olivier ;

Storme, Guy ;

Bernier, Jacques ;

Kuten, Abraham ;

Sternberg, Cora ;

Billiet, Ignace ;

Lopez Torecilla, Jose ;

Pfeffer, Raphael ;

Cutajar, Carmel Lino ;

Van der Kwast, Theodore ;

Collette, Laurence .

LANCET ONCOLOGY, 2010, 11 (11) :1066-1073

[6] The Levels of Evidence and Their Role in Evidence-Based Medicine [J].

Burns, Patricia B. ;

Rohrich, Rod J. ;

Chung, Kevin C. .

PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 128 (01) :305-310

[7] A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update [J].

Buyyounouski, Mark K. ;

Davis, Brian J. ;

Prestidge, Bradley R. ;

Shanahan, Thomas G. ;

Stock, Richard G. ;

Grimm, Peter D. ;

Demanes, D. Jeffrey ;

Zaider, Marco ;

Horwitz, Eric M. .

BRACHYTHERAPY, 2012, 11 (04) :299-305

[8]

Chang AJ, 2018, J CLIN ONCOL

[9] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].

Chang, Joe Y. ;

Senan, Suresh ;

Paul, Marinus A. ;

Mehran, Reza J. ;

Louie, Alexander V. ;

Balter, Peter ;

Groen, Harry J. M. ;

McRae, Stephen E. ;

Widder, Joachim ;

Feng, Lei ;

van den Borne, Ben E. E. M. ;

Munsell, Mark F. ;

Hurkmans, Coen ;

Berry, Donald A. ;

van Werkhoven, Erik ;

Kresl, John J. ;

Dingemans, Anne-Marie ;

Dawood, Omar ;

Haasbeek, Cornelis J. A. ;

Carpenter, Larry S. ;

De Jaeger, Katrien ;

Komaki, Ritsuko ;

Slotman, Ben J. ;

Smit, Egbert F. ;

Roth, Jack A. .

LANCET ONCOLOGY, 2015, 16 (06) :630-637

[10] Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update [J].

Chin, Joseph ;

Rumble, R. Bryan ;

Kollmeier, Marisa ;

Heath, Elisabeth ;

Efstathiou, Jason ;

Dorff, Tanya ;

Berman, Barry ;

Feifer, Andrew ;

Jacques, Arthur ;

Loblaw, D. Andrew .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (15) :1737-+

← 1 2 3 4 5 6 7 8 →